134 related articles for article (PubMed ID: 8528239)
1. Achondrogenesis type IB is caused by mutations in the diastrophic dysplasia sulphate transporter gene.
Superti-Furga A; Hästbacka J; Wilcox WR; Cohn DH; van der Harten HJ; Rossi A; Blau N; Rimoin DL; Steinmann B; Lander ES; Gitzelmann R
Nat Genet; 1996 Jan; 12(1):100-2. PubMed ID: 8528239
[No Abstract] [Full Text] [Related]
2. Mutational analysis of the DTDST gene in a fetus with achondrogenesis type 1B.
Cai G; Nakayama M; Hiraki Y; Ozono K
Am J Med Genet; 1998 Jun; 78(1):58-60. PubMed ID: 9637425
[TBL] [Abstract][Full Text] [Related]
3. Undersulfation of proteoglycans synthesized by chondrocytes from a patient with achondrogenesis type 1B homozygous for an L483P substitution in the diastrophic dysplasia sulfate transporter.
Rossi A; Bonaventure J; Delezoide AL; Cetta G; Superti-Furga A
J Biol Chem; 1996 Aug; 271(31):18456-64. PubMed ID: 8702490
[TBL] [Abstract][Full Text] [Related]
4. Functional expression and cellular distribution of diastrophic dysplasia sulfate transporter (DTDST) gene mutations in HEK cells.
Karniski LP
Hum Mol Genet; 2004 Oct; 13(19):2165-71. PubMed ID: 15294877
[TBL] [Abstract][Full Text] [Related]
5. A family of chondrodysplasias caused by mutations in the diastrophic dysplasia sulfate transporter gene and associated with impaired sulfation of proteoglycans.
Superti-Furga A; Hästbacka J; Rossi A; van der Harten JJ; Wilcox WR; Cohn DH; Rimoin DL; Steinmann B; Lander ES; Gitzelmann R
Ann N Y Acad Sci; 1996 Jun; 785():195-201. PubMed ID: 8702127
[No Abstract] [Full Text] [Related]
6. A chondrodysplasia family produced by mutations in the diastrophic dysplasia sulfate transporter gene: genotype/phenotype correlations.
Superti-Furga A; Rossi A; Steinmann B; Gitzelmann R
Am J Med Genet; 1996 May; 63(1):144-7. PubMed ID: 8723100
[TBL] [Abstract][Full Text] [Related]
7. Atelosteogenesis type II is caused by mutations in the diastrophic dysplasia sulfate-transporter gene (DTDST): evidence for a phenotypic series involving three chondrodysplasias.
Hästbacka J; Superti-Furga A; Wilcox WR; Rimoin DL; Cohn DH; Lander ES
Am J Hum Genet; 1996 Feb; 58(2):255-62. PubMed ID: 8571951
[TBL] [Abstract][Full Text] [Related]
8. In vitro proteoglycan sulfation derived from sulfhydryl compounds in sulfate transporter chondrodysplasias.
Rossi A; Cetta G; Piazza R; Bonaventure J; Steinmann B; Supereti-Furga A
Pediatr Pathol Mol Med; 2003; 22(4):311-21. PubMed ID: 14692227
[TBL] [Abstract][Full Text] [Related]
9. SLC26A2 (diastrophic dysplasia sulfate transporter) is expressed in developing and mature cartilage but also in other tissues and cell types.
Haila S; Hästbacka J; Böhling T; Karjalainen-Lindsberg ML; Kere J; Saarialho-Kere U
J Histochem Cytochem; 2001 Aug; 49(8):973-82. PubMed ID: 11457925
[TBL] [Abstract][Full Text] [Related]
10. Undersulfation of cartilage proteoglycans ex vivo and increased contribution of amino acid sulfur to sulfation in vitro in McAlister dysplasia/atelosteogenesis type 2.
Rossi A; Bonaventure J; Delezoide AL; Superti-Furga A; Cetta G
Eur J Biochem; 1997 Sep; 248(3):741-7. PubMed ID: 9342225
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the diastrophic dysplasia sulfate transporter (DTDST) gene: correlation between sulfate transport activity and chondrodysplasia phenotype.
Karniski LP
Hum Mol Genet; 2001 Jul; 10(14):1485-90. PubMed ID: 11448940
[TBL] [Abstract][Full Text] [Related]
12. Proteoglycan sulfation in cartilage and cell cultures from patients with sulfate transporter chondrodysplasias: relationship to clinical severity and indications on the role of intracellular sulfate production.
Rossi A; Kaitila I; Wilcox WR; Rimoin DL; Steinmann B; Cetta G; Superti-Furga A
Matrix Biol; 1998 Oct; 17(5):361-9. PubMed ID: 9822202
[TBL] [Abstract][Full Text] [Related]
13. Achondrogenesis type 1B.
Superti-Furga A
J Med Genet; 1996 Nov; 33(11):957-61. PubMed ID: 8950678
[No Abstract] [Full Text] [Related]
14. Dysplastic histogenesis of cartilage growth plate by alteration of sulphation pathway: a transgenic model.
Cornaglia AI; Casasco A; Casasco M; Riva F; Necchi V
Connect Tissue Res; 2009; 50(4):232-42. PubMed ID: 19637059
[TBL] [Abstract][Full Text] [Related]
15. Cartilage disorders. The importance of being sulphated.
Wallis GA
Curr Biol; 1995 Mar; 5(3):225-7. PubMed ID: 7780725
[TBL] [Abstract][Full Text] [Related]
16. Achondrogenesis type IB: agenesis of cartilage interterritorial matrix as the link between gene defect and pathological skeletal phenotype.
Corsi A; Riminucci M; Fisher LW; Bianco P
Arch Pathol Lab Med; 2001 Oct; 125(10):1375-8. PubMed ID: 11570921
[TBL] [Abstract][Full Text] [Related]
17. Cloning and characterization of the 5'-flanking region of the mouse diastrophic dysplasia sulfate transporter gene.
Kobayashi T; Sugimoto T; Saijoh K; Fujii M; Chihara K
Biochem Biophys Res Commun; 1997 Sep; 238(3):738-43. PubMed ID: 9325159
[TBL] [Abstract][Full Text] [Related]
18. Functional analysis of diastrophic dysplasia sulfate transporter. Its involvement in growth regulation of chondrocytes mediated by sulfated proteoglycans.
Satoh H; Susaki M; Shukunami C; Iyama K; Negoro T; Hiraki Y
J Biol Chem; 1998 May; 273(20):12307-15. PubMed ID: 9575183
[TBL] [Abstract][Full Text] [Related]
19. Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS).
Everett LA; Glaser B; Beck JC; Idol JR; Buchs A; Heyman M; Adawi F; Hazani E; Nassir E; Baxevanis AD; Sheffield VC; Green ED
Nat Genet; 1997 Dec; 17(4):411-22. PubMed ID: 9398842
[TBL] [Abstract][Full Text] [Related]
20. Phenotypic and genotypic overlap between atelosteogenesis type 2 and diastrophic dysplasia.
Rossi A; van der Harten HJ; Beemer FA; Kleijer WJ; Gitzelmann R; Steinmann B; Superti-Furga A
Hum Genet; 1996 Dec; 98(6):657-61. PubMed ID: 8931695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
